Summary
Currently, no protocol exists that can assess the metastatic potential of prostate adenocarcinoma. The reason for this is partly due to the lack of information on cellular changes that result in a tumor cell's becoming metastatic. In this investigation, attempts were made to devise a method that correlated with the metastatic potential of AT-1, Mat-Lu, and Mat-LyLu cell lines of the Dunning R-3327 rat prostatic adenocarcinoma system. To accomplish this, we applied BioQuant biometric parameters, i.e., area, shape factor, and cell motility. AT-1 had a lower shape factor and a greater area as compared with the more highly metastatic Mat-Lu subline. No significant difference in area or shape factor was detected between the AT-1 cell line and the highly metastatic Mat-LyLu line. However, the lowly metastatic AT-1 line had less motility as compared with the Mat-Lu and Mat-LyLu lines. This study revealed that metastatic potential could be partially predicted via area and shape factor and accurately predicted via cell motility.
Similar content being viewed by others
References
Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson J (1983) Molecular biology of the cell. Garland, New York, pp 615–616
Benson MC, Olsson CA (1989) The staging and grading of prostatic cancer. In: Fitzpatrick JM, Krane RJ (eds) The prostate. Churchill Livingstone, New York, pp 261–272
Blood CH, Zetter BR (1990) Tumor interaction with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1032:89–118
Carter BH, Coffey D (1988) Cell surface charge in predicting metastatic potential of aspirated cells from the Dunning rat prostatic adenocarcinoma model. J Urol 140:173–175
Carter BH, Isaacs JT (1990) Why do cells metastasize? World J Urol 8:2–5
Carter BH, Partin AW, Coffey DS (1989) Prediction of metastatic potential in a animal model of prostate cancer: flow cytometric quantification of cell surface charge. J Urol 142:1338–1341
Catalona WJ, Scott WW (1988) Carcinoma of the prostate. In: Harrison JH, et al (eds) Campbell's urology. W. B. Saunders, Philadelphia, pp 1085–1124
Dalton L (1992) Computer-based image analysis of prostate cancer: comments with emphasis on use of commercially available systems. Hum Pathol 23:280–286
Dunning WF (1963) Prostate cancer in the rat. Natl Cancer Inst Monogr 12:351–369
Foster CS, Mostofi FK (1992) Prostate cancer: present status. Hum Pathol 23:209–210
Harris-Hooker S, Sanford GL, Montgomery V, Rivers R, Emmett N (1992) Influence of low ensity lipoproteins on vascular smooth muscle cell growth and motility: modulation by extracellular matrix. Cell Biol Int Rep 16:433–450
Isaacs JT (1987) Development and characteristics of the available animal model systems for the study of prostate. In: Coffey DS, Bruchovsky N, Gardner NA, Resnick MI, Karr JP (eds) Current content and approaches to the study of prostate cancer. Alan R. Liss, New York, pp 513–576
Isaacs JT, Isaacs WB, Feitz WFJ, Scheres J (1986) Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostate cancers. Prostate 9:261–281
Liotta LA (1992) Cancer cell invasion and metastasis. Sci Am 266:54–63
Lowe FC, Isaacs JT (1984) Biochemical methods for predicting metastatic ability of prostate cancer utilizing the Dunning R-3327 rat prostatic adenocarcinoma as a model. Cancer Res 44:744–752
Mohler JL, Partin AW, Coffey DS (1987) Prediction of metastatic potential by a new grading system of cell motility: validation in the Dunning R-3327 prostatic adenocarcinoma model. J Urol 138:168–170
Mohler J, Partin A, Isaacs WB, Coffey D (1987) Time lapse video microscopic identification of Dunning R-3327 adenocarcinoma and normal rat prostate cells. J Urol 137:544–547
Mohler JL, Partin AW, Isaacs JT, Coffey DS (1988) Metastatic potential prediction by a visual grading system of cell motility: prospective validation in the Dunning R-3327 prostatic adenocarcinoma model. Cancer Res 48:4312–4317
Partin AW, Schoeniger JS, Mohler JL, Coffey DS (1989) Fourier analysis of cell motility: correlation of motility with metastatic potential. Proc Natl Acad Sci USA 86:1254–1258
Poel HG van der, Schalken JA, Debruyne FMJ (1991) Image analysis and grading of prostate adenocarcinoma. World J Urol 9:86–94
Ramaekers FCS, Verhagen APM, Isaacs JT, Feitz WFJ, Moesker O, Schaart G, Schalken JA, Voojs GP (1989) Intermediate filament expression and the progression of prostatic cancer as studied in the Dunning R-3327 rat prostatic carcinoma system. Prostate 14:323–339
Zachary JM, Cleveland G, Kwock L, Lawrence T, Wessman RM, Nabell L, Fried FA, Staab EV, Risinger MA, Lin S (1984) Actin filament organization of the Dunning R-3327 rat prostatic adenocarcinoma system: correlation with metastatic potential. Cancer Res 46:926–932
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cooper, C.R., Emmett, N., Harris-Hooker, S. et al. Biometric assessment of prostate cancer's metastatic potential. World J Urol 12, 304–307 (1994). https://doi.org/10.1007/BF00184108
Issue Date:
DOI: https://doi.org/10.1007/BF00184108